Version 2.73

62807-3PhenX - serum creatinine assay for kidney function protocol 141401Trial

Status Information


Term Description

This protocol provides instructions for drawing, processing and storing blood for the serum creatinine assay according to the National Health and Nutrition Examination Survey (NHANES) methods. Creatinine concentration in a participant's serum is measured according to the Jaffe rate method. The Diabetes Working Group notes that the Serum Creatinine assay can be done in conjunction with Cystatin C assay (see Diabetes Supplemental Information Cystatin C) to yield more information about kidney disease. In particular, comparing and contrasting the polymorphisms associated with each assay can identify "true" markers for kidney function (see Kottgen et al., 2009 for more information).
Source: Regenstrief LOINC

Panel Hierarchy
Details for each LOINC in Panel LHC-Forms

LOINC Name R/O/C Cardinality Example UCUM Units
62807-3 PhenX - serum creatinine assay for kidney function protocol 141401
Indent66177-7 Do you have hemophilia?
Indent66178-5 Have you received cancer chemotherapy in the past four weeks or do you anticipate such therapy in the next four weeks?
Indent66504-2 Exclusion Criteria
Indent66180-1 Was blood drawn?
Indent66181-9 Was full sample obtained?
Indent8251-1 Service comment
Indent8251-1 Service comment
Indent66200-7 Repeatability of the assay {ratio}
Indent66201-5 Coefficient of variation for the assay {CV}

Fully-Specified Name

PhenX - serum creatinine assay for kidney function protocol 141401

Additional Names

Short Name
Serum creatinine assay proto

Survey Question


Basic Attributes

First Released
Version 2.36
Last Updated
Version 2.66
Change Reason
Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Added the PhenX protocol ID to the Component to clearly define the protocol version for which this panel is based upon.
Panel Type

Reference Information

Type Source Reference
Article Consensus measures for Phenotypes and Exposures American Diabetes Association. (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care, 33 (Supplement 1), S11 - S61.
Citation Consensus measures for Phenotypes and Exposures Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Questionnaire. Laboratory Procedures Manual. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2007.
Article Consensus measures for Phenotypes and Exposures Kottgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R, Li M, Yang Q, Gudnason V, Launer LJ, Harris TB, Smith AV, Arking DE, Astor BC, Boerwinkle E, Ehret GB, Ruczinski I, Scharpf RB, Ida Chen YD, de Boer IH, Haritunians T, Lumley T, Sarnak M, Siscovick D, Benjamin EJ, Levy D, Upadhyay A, Aulchenko YS, Hofman A, Rivadeneira F, Uitterlinden AG, van Duijn CM, Chasman DI, Par¿, Ridker PM, Kao WH, Witteman JC, Coresh J, Shlipak MG, & Fox CS. (2009). Multiple loci associated with indices of renal function and chronic kidney disease. Nature Genetics. 41(6), 712-717

Member of these Panels

LOINC Long Common Name
62787-7 PhenX domain - Diabetes

Language Variants Get Info

zh-CNChinese (China)
PhenX - 肾功能血清肌酐检测方案 141401:-:时间点:^患者:-:PhenX
it-ITItalian (Italy)
PhenX - test della creatinina sierica per la funzione renale, protocollo:-:Pt:^Paziente:-:PhenX
ru-RURussian (Russian Federation)
PhenX - сывороточный креатинин анализ на функцию почек протокол:-:ТчкВрм:^Пациент:-:PhenX
es-MXSpanish (Mexico)
PhenX: ensayo de creatinina sérica para la función renal protocolo 141401:-:Punto temporal:^ Paciente:-:PhenX

LOINC FHIR® API Example - CodeSystem and Questionnaire Requests Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=62807-3 https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/62807-3